Common Product Development Mistakes and How to Avoid Them

The most expensive product development mistakes rarely begin in the laboratory. They usually start with an unclear customer, an unrealistic cost target, packaging ordered too early, unsupported claims, uncontrolled revisions or a launch date announced before the critical work has been mapped.

A strong formula cannot rescue a weak commercial plan. Likewise, a commercially attractive concept can fail if the formula, packaging, testing and production process are treated as separate decisions. Successful development requires the brand, formulator, manufacturer, testing partners and packaging suppliers to work from one controlled brief.

This guide examines the mistakes Australian founders and established brands commonly make when developing skincare, haircare, cosmetics, supplements and other formulated products. Each section explains why the problem occurs, what it can cost and how to prevent it.

Mistake 1: Starting with ingredients instead of the customer

Many briefs begin with a list of fashionable ingredients copied from competitor products or social media. The list may sound impressive, but it does not explain who the product serves, the problem it solves, how it should feel, what it should cost or why someone would repurchase it.

Ingredients must perform a role within a complete formula. More ingredients can create higher cost, flavour or fragrance problems, processing challenges, instability and confused positioning. A rinse-off cleanser and a leave-on serum, for example, should not use identical ingredient logic simply because the same actives are popular.

How to avoid it

Define the customer, use occasion, format, sensory experience, price position and product promise before finalising ingredient requests. Separate essential ingredients from optional marketing ideas and explain why each is relevant.

Mistake 2: Trying to launch the entire range at once

Founders often believe that a brand needs a complete collection on launch day. This can divide a limited budget across multiple development programs, testing plans, packaging components and production runs before demand has been validated.

A six-product range can also create six sets of decisions and dependencies. One delayed component may hold up photography, bundles or the entire launch. Inventory can become fragmented across products with very different sales velocity.

How to avoid it

Share the complete roadmap with the manufacturer, then rank products by commercial importance. Consider launching one hero product or a focused pair that clearly demonstrates the brand proposition. Use real customer and sales information to guide later extensions.

Mistake 3: Choosing the wrong development pathway

Custom formulation is not automatically superior to private label, and private label is not automatically the fastest or cheapest answer for every concept. The correct pathway depends on differentiation, claims, budget, timing, packaging and required performance.

A founder may pay for custom development even though an existing formula fits the customer well. Another brand may attempt to force substantial changes into a private label base until the project effectively becomes custom work without being planned or priced that way.

How to avoid it

Compare the scope and trade-offs of private label, semi-custom, custom formulation, reformulation and contract filling. Skincare brands can review the private label skin care range and APL’s custom cosmetic formulation service.

Mistake 4: Hiding the budget

Some founders avoid discussing budget because they fear the quote will simply rise to match it. In practice, a realistic range helps the development team recommend formats, ingredients, packaging and pathways that have a chance of reaching commercial production.

Without a budget, the project may progress toward a beautiful sample that the brand cannot afford to manufacture, test or package. Development fees are only one part of the investment.

How to avoid it

Prepare separate allowances for development, samples, testing, packaging, artwork, production, freight, launch inventory and marketing. Confirm what each proposal includes and excludes.

Mistake 5: Setting a unit-cost target without a retail model

A target cost cannot be assessed properly without the retail price and sales channel. Direct-to-consumer, wholesale, retail distribution and export may require different margins and support costs.

A product that appears profitable when sold at full price on a website may not support retailer margin, distributor margin, discounts, freight, fulfilment, returns and customer acquisition.

How to avoid it

Build the price backwards through the intended sales chain. Give the manufacturer the target retail price, wholesale assumptions, fill size, first order and forecast so formula and packaging decisions can be commercially grounded.

Mistake 6: Ordering packaging before formula assessment

Packaging is frequently ordered early because it has a long lead time or because the founder is excited to see the brand become tangible. Unfortunately, the component may not suit the final viscosity, product chemistry, filling equipment, label requirements or production quantity.

Problems can include pumps that do not dispense, tubes that cannot be sealed on available equipment, materials that interact with the formula, insufficient label space and component minimums far above the manufacturing run.

How to avoid it

Select a packaging direction during scoping but wait for technical and filling review before placing a bulk order. Obtain supplier specifications, samples, minimums and lead times. Plan appropriate packaging compatibility testing where relevant.

Mistake 7: Treating claims as last-minute copywriting

Claims affect product category, formulation, ingredients, evidence, testing and artwork. Adding statements such as clinically proven, sensitive, non-comedogenic, microbiome-friendly or therapeutic after development can create a mismatch between the marketing and the product evidence.

The risk is not limited to the label. Product pages, advertisements, retailer listings and founder content also create representations about the product.

How to avoid it

Draft intended claims during the brief. Review the exact wording, where it will be used and what evidence may be needed. Keep claims aligned across every customer touchpoint.

Mistake 8: Assuming one test covers every risk

A stability report, microbiological result or packaging check answers a defined question. It does not automatically establish complete safety, regulatory compliance, claim support or suitability for every market.

Testing needs vary by formula, product type, packaging, use, claims and destination. Some tests require production-representative samples or final packaging and cannot be meaningfully completed using an early concept sample.

How to avoid it

Build a written, project-specific testing plan. Clarify the sample, method, conditions, time points, acceptance criteria and responsibility for each report. Explore APL’s product testing options early in development.

Mistake 9: Giving vague or conflicting sample feedback

Comments such as “make it more premium,” “make it cleaner” or “it needs more wow” do not identify a technical change. When several founders provide separate feedback, the formulator may receive contradictory instructions.

Uncontrolled feedback increases sample rounds and can move the formula away from the original brief. It also makes it difficult to determine which version was approved.

How to avoid it

Nominate one decision-maker and consolidate feedback. Refer to the sample code and comment on observable characteristics: viscosity, fragrance strength, colour, spread, lather, rinse, absorption, flavour, sweetness, texture or aftertaste. Identify what must change and what is already approved.

Read how sampling and formula revisions work for a structured approval process.

Mistake 10: Changing the brief during development

A normal revision adjusts the sample toward the agreed brief. A request for a different format, customer, fragrance system, ingredient strategy, packaging or price position may be a new brief.

Repeated strategic changes waste development work and make budgets and timelines unreliable. They often occur when founders have not aligned internally before engaging the laboratory.

How to avoid it

Approve the commercial brief before sampling. If the strategy genuinely changes, pause and re-scope the project rather than disguising the change as one more sample revision.

Mistake 11: Assuming the laboratory sample will scale automatically

Commercial equipment behaves differently from laboratory tools. Mixing, heating, cooling, shear, addition order, batch depth and filling can affect the result. A formula that looks correct in a small vessel still requires an appropriate manufacturing process.

How to avoid it

Ensure the manufacturer reviews the formula, method, raw materials, specifications and equipment. Allow for scale-up work and quality assessment. See what happens during manufacturing scale-up.

Mistake 12: Announcing the launch date too early

A public date creates pressure to skip decisions or accept unresolved risks. Development timing depends on sample approvals, testing, raw materials, packaging, artwork, production schedules and freight.

Packaging suppliers and external laboratories operate on their own timelines. A formula being approved does not mean every other dependency is ready.

How to avoid it

Map the critical path and include contingency. Treat the launch date as provisional until the main dependencies have been confirmed. Build marketing in parallel using approved information, but avoid commitments that force unsafe shortcuts.

Mistake 13: Comparing manufacturers only on unit price

Two quotations may include different services, raw materials, packaging assumptions, documentation, testing coordination and quality processes. A lower number is not necessarily a like-for-like comparison.

How to avoid it

Compare the complete pathway: development scope, sample rounds, scale-up, manufacturing, filling, packaging responsibilities, minimums, quality records, testing, payment terms and exclusions. Understand the work required to reach finished goods, not merely the quoted bulk price.

Mistake 14: Failing to confirm formula ownership

Private label formulas are commonly owned by the supplier. Custom formula ownership depends on the contract. Paying for development does not automatically transfer intellectual property, and possessing an ingredient list is not the same as holding a transferable production formula.

How to avoid it

Confirm ownership, licensing, confidentiality, permitted use, transfer documentation and any manufacturing obligations in writing before development begins.

Mistake 15: Ignoring the reorder before the launch

Brands often focus entirely on first production and do not model replenishment. Strong sales can then create a stockout because raw materials, packaging and manufacturing slots cannot be secured immediately.

How to avoid it

Understand the complete reorder lead time, retain current specifications and artwork, monitor component inventory and set a reorder trigger based on sales velocity and supplier timing.

A better product development sequence

1. Define the customer, problem, product promise and sales channel.
2. Map the complete range and choose the first priority.
3. Set retail price, budget, quantity and annual forecast.
4. Choose the appropriate development pathway.
5. Complete the formula, sensory, ingredient and claims brief.
6. Align packaging with the formula and filling process.
7. Prepare and approve coded samples using structured feedback.
8. Confirm testing, specifications and regulatory responsibilities.
9. Finalise packaging, artwork and documentation.
10. Complete scale-up, production, filling and quality release.
11. Launch using approved information and monitor feedback.
12. Reorder before inventory reaches the critical level.

The private label manufacturing checklist expands these stages into a complete founder-ready planning tool.

Frequently asked questions

What is the most common product development mistake?

The root problem is usually an incomplete or changing brief. It creates downstream confusion in formulation, cost, packaging, testing and timing.

Should I develop one product or a full range?

Share the full roadmap, but select priorities based on budget, commercial importance, minimums and operational capacity. A focused launch can reduce risk.

When should packaging be ordered?

Packaging direction should be discussed early, but bulk orders should wait until component suitability, filling, compatibility, minimums and artwork requirements have been assessed.

How many sample revisions should I expect?

The number depends on the scope and agreement. Clear briefs and consolidated feedback reduce unnecessary rounds. A changed commercial strategy may need a new scope.

Can testing happen after production?

Some checks relate to production batches, but many testing decisions must be made earlier because they affect formula approval, packaging, claims and launch timing.

How do I know whether a quote is complete?

Ask what is included and excluded across development, raw materials, packaging, filling, testing, documentation, freight, setup and quality work.

Develop products with Australian Private Label

Australian Private Label supports founders and established brands through private label products, custom formulation, testing and commercial manufacturing. APL assesses each project on its technical and commercial requirements.

Explore private label skin care, custom cosmetic development, supplement development and product testing services.

Important: This article provides general commercial information and is not legal, regulatory or technical advice for a specific product. Formula feasibility, testing, claims, ownership, minimums, costs and timing must be confirmed for each project.